Our research spans five key themes:
Patient/Public Preferences, Economic Evaluation, System & Equity, Quality of Life, and Costing
Patient/Public Preferences
-
BabyScreen+: Genomic newborn screening for personalised lifelong healthcare in Australian babies
-
National precision health research translation for breast and prostate cancer prevention and early detection
-
Our DNA
-
Introducing Mitochondrial Donation into Australia: The MitoHOPE (Healthy Outcomes Pilot and Evaluation) Program
-
Trial Integration of Polygenic Scores for Common Cancers into Standard Clinical Care
-
Valuing the benefits of genomic testing across clinical contexts using discrete choice experiment methods, Australian Genomics
Economic Evaluation
-
Investment case for human genomic applications
-
BabyScreen+: Genomic newborn screening for personalised lifelong healthcare in Australian babies
-
National precision health research translation for breast and prostate cancer prevention and early detection
-
The Australian Undiagnosed Diseases Network (UDN-Aus): An internationally networked national approach for transforming diagnosis for individuals living with rare diseases
-
Introducing Mitochondrial Donation into Australia: The MitoHOPE (Healthy Outcomes Pilot and Evaluation) Program
-
Trial Integration of Polygenic Scores for Common Cancers into Standard Clinical Care
System & Equity
-
BabyScreen+: Genomic newborn screening for personalised lifelong healthcare in Australian babies
-
National precision health research translation for breast and prostate cancer prevention and early detection
-
Our DNA
-
Introducing Mitochondrial Donation into Australia: The MitoHOPE (Healthy Outcomes Pilot and Evaluation) Program
-
Trial Integration of Polygenic Scores for Common Cancers into Standard Clinical Care
-
Evidence review to inform development of the National Framework for Genomics in Cancer Control
-
Standardizing how we measure the value of genomic medicine to inform healthcare decision-making in Australia and beyond